Evidence map›Paper›PMID 25752730›Full record

ArticleMolecular and cellular neurosciences2015

Alternative splicing of the LIM-homeodomain transcription factor Isl1 in the mouse retina.

Irene E Whitney, Amanda G Kautzman, Benjamin E Reese

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular neurosciences, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Cloning and Functional Analysis ofInternational journal of molecular sciences · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Irene E WhitneyNeuroscience Research Institute, University of California at Santa Barbara, Santa Barbara, CA 93106-5060, United States; Department of Molecular, Cellular and Developmental Biology, University of California at Santa Barbara, Santa Barbara, CA 93106-9625, United States. Electronic address: irenewhitney@fas.harvard.edu.
Amanda G KautzmanNeuroscience Research Institute, University of California at Santa Barbara, Santa Barbara, CA 93106-5060, United States; Department of Psychological & Brain Sciences, University of California at Santa Barbara, Santa Barbara, CA 93106-9660, United States. Electronic address: kautzman@psych.ucsb.edu.
Benjamin E ReeseNeuroscience Research Institute, University of California at Santa Barbara, Santa Barbara, CA 93106-5060, United States; Department of Psychological & Brain Sciences, University of California at Santa Barbara, Santa Barbara, CA 93106-9660, United States. Electronic address: breese@psych.ucsb.edu.
University of California, Santa Barbara · US

Funding

Development of Retinal Bipolar CellsR01EY019968 · NEI · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI REESE, BENJAMIN E · 2010 to 2023
$4.9M
NEI NIH HHS EY019968NEI NIH HHS R01 EY019968
6 · The paper itself

Abstract

Islet-1 (Isl1) is a LIM-homeodomain (LIM-HD) transcription factor that functions in a combinatorial manner with other LIM-HD proteins to direct the differentiation of distinct cell types within the central nervous system and many other tissues. A study of pancreatic cell lines showed that Isl1 is alternatively spliced generating a second isoform, Isl1β, which is missing 23 amino acids within the C-terminal region. This study examines the expression of the canonical and alternative Isl1 transcripts across other tissues, in particular, within the retina, where Isl1 is required for the differentiation of multiple neuronal cell types. The alternative splicing of Isl1 is shown to occur in multiple tissues, but the relative abundance of Isl1α and Isl1β expression varies greatly across them. In most tissues, Isl1α is the more abundant transcript, but in others the transcripts are expressed equally, or the alternative splice variant is dominant. Within the retina, differential expression of the two Isl1 transcripts increases as a function of development, with dynamic changes in expression peaking at E16.5 and again at P10. At the cellular level, individual retinal ganglion cells vary in their expression, with a subset of small-to-medium sized cells expressing only the alternative isoform. The functional significance of the difference in protein sequence between the two Isl1 isoforms was also assessed using a luciferase assay, demonstrating that the alternative isoform forms a less effective transcriptional complex for activating gene expression. These results demonstrate the differential presence of the canonical and alternative isoforms of Isl1 amongst retinal ganglion cell classes. As Isl1 participates in the differentiation of multiple cell types within the CNS, the present results support a role for alternative splicing in the establishment of cellular diversity in the developing nervous system.

Indexed as

Alternative SplicingAmino Acid SequenceAnimalsLIM-Homeodomain ProteinsMiceMice, Inbred C57BLMolecular Sequence DataOrgan SpecificityProtein IsoformsProtein Structure, TertiaryRetinaRNA, MessengerTranscription Factorsinsulin gene enhancer binding protein Isl-1LIM-Homeodomain ProteinsProtein IsoformsRNA, MessengerTranscription FactorsDifferentiationGene expressionIsoformRetinal ganglion cellSplice variant

Identifiers

PMID25752730
PMCPMC4393802
OpenAlexW2022325917

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.